EFdA (Islatravir): An Outstanding Anti-HIV Modified Nucleoside: From Conceptualization to Present-Day Clinical Findings - Softcover

Inhaltsangabe

EFdA(4’-C-ethynyl-2-fluoro-2’-deoxyadenosine), named Islatravir by Merck, is a very excellent anti-HIV modified nucleoside. The story of its development, especially the basis of its design, advances in its synthetic methods, amazing clinical results and unexpected clinical results, and further, the possibility of EFdA as the clinical medicine, is described.

Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.